Biogen Departure Train Chugs on as Two Board Members Exit
Summary : One week after Johnna Rossell departed Biogen for Enzyvant, the embattled company announced that two members of its board of…
Summary : One week after Johnna Rossell departed Biogen for Enzyvant, the embattled company announced that two members of its board of…
Synopsis : Granules India Ltd on Thursday said it has received approval from the US health regulator for its generic Amphetamine mixed…
Summary : Interpace Biosciences, Inc. (OTCQX: IDXG) (“Interpace” or the “Company”) a leader in enabling personalized medicine, announced today that it was…
Synopsis : Biogen is selling its nearly 50% stake in South Korea-based Samsung Bioepis for $2.3 billion. The move will provide Biogen…
Courtesy of Alzamend Neuro On the strength of data from its Phase 1 Study of lead compound, AL001, being developed for…
Summary : Oxford Biomedica and Homology Medicines to establish Oxford Biomedica Solutions LLC, a new U.S.-based AAV Manufacturing and Innovation Business Homology…
Summay : EAMS scientific opinion issued to Global Blood Therapeutics (UK) Ltd for Voxelotor in the treatment of hemolytic anemia in patients…
Summary : A high-level delegation from Colombia led by Marta Lucia Ramirez de Rincn, Vice-President and Minister of Foreign Affairs, visited Department…
Summary : Xebra Brands Ltd. , a cannabis company, is pleased to announce that it has satisfied all conditions pursuant to its…
Summary : Today, Cellino Biotech , an autonomous cell therapy manufacturing company, announced an $80 million Series A financing round led by…